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We have reported [( 1984) Cancer Res., in press] that estramustine phosphate inhibits microtubule assembly 
and disassembled preformed microtubules. We now present evidence that estramustine phosphate inhibits 
microtubule assembly by binding to the microtubule-associated proteins. We have found that: (1) additional 
microtubule-associated proteins relieved the inhibition of assembly by estramustine phosphate; (2) 3H-la- 
belled estramustine phosphate bound predominantly to the microtubule-associated proteins; and (3) the 
content of the microtubule-associated proteins was reduced in taxol reversed estramustine phosphate-inhib- 
ited microtubules. 
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1. INTRODUCTION 
Estramustine phosphate, estradiol-3-[N,N- 
bis(2-chloroethyl)carbamate] 17&phosphate, is ac- 
tive against advanced prostatic carcinoma [2]. It 
exhibits several classical mitotic inhibitory 
characteristics: it is cytotoxic and induces mitotic 
arrest at metaphase [3,4]. However, its mechanism 
of action has been unknown. We reported that 
estramustine phosphate inhibits assembly and 
disassembles microtubules isolated from bovine 
brain. These results indicated that the cytotoxicity 
of estramustine phosphate might be caused by in- 
terference with the microtubule proteins. 
Microtubule proteins consist of 80% tubulin and 
20% microtubule-associated proteins. Mitotic in- 
hibitors such as colchicine, vinblastine and 
nocodazole [5] inhibit assembly of microtubules by 
interacting with tubulin, the subunit of the 
microtubule-backbone. However, the effect of 
estramustine phosphate on microtubule assembly 
Abbreviations: Pipes, piperazine-N,N’-bis(Zethanesul- 
phonic acid); MAPS, microtubule-associated proteins 
was different from that of these tubulin-binding 
drugs [l]. It was therefore of main interest to fur- 
ther characterize the interaction of estramustine 
phosphate with the microtubule proteins. Here, 
additional microtubule-associated proteins were 
found to counteract the inhibitory effect of 
estramustine phosphate on microtubules. Further- 
more, 3H-labelled estramustine phosphate 
predominantly bound to the microtubule- 
associated proteins, but to a lesser extent to 
tubulin. Moreover, the amount of microtubule- 
associated proteins was reduced in microtubules 
reassembled by taxol in the presence of 
estramustine phosphate. Our results thus suggest 
that estramustine phosphate belongs to a new class 
of microtubule inhibitors, which bind to the 
microtubule-associated proteins and not to 
tubulin. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
Estramustine phosphate, estradiol-3-[N,N-bis- 
(2-chloroethyl)carbamate] 17,&phosphate, and 
estramustine [6,7-3H]phosphate were synthesized 
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by AB Leo, Helsingborg, Sweden. Estramustine 
phosphate was dissolved in distilled water and its 
concentration estimated from the absorbance at 
274 nm using the extinction coefficient of 
estramustine, ErvO = 17.7 (AB Leo, personal com- 
munication). In all the experiments with the drug 
the solutions contained 1 mM EDTA to avoid 
precipitation of an insoluble Ca2+ or Mg*+ 
estramustine phosphate complex. No difference in 
assembly characteristics was seen in the presence of 
1 mM EDTA. 
Tax01 was a gift from Dr M. Sufness at the Na- 
tional Institute of Health, Bethesda, MD 20205, 
USA. All other chemicals were reagent grade. 
2.2. Microtubule proteins 
Microtubule proteins were prepared from 
bovine brain in the absence of glycerol by two or 
three cycles of assembly-disassembly in the 
presence of 0.5 mM MgS04 [6,7]. In the first cycle 
EGTA was present o complex free Ca*+ . The final 
pellet, which contains approximately 80% tubulin, 
was stored in liquid nitrogen. Prior to use, the 
pellet was re-suspended in buffer (0.1 M Pipes, 
0.5 mM MgS04, with 1 mM GTP at pH 6.8). 
After incubation at 4°C for 30 min, the sample 
was centrifuged at 35000 x g for 30 min at 4°C. 
The microtubule-associated proteins (MAPS) 
were separated from tubulin by ion-exchange 
chromatography on a column containing from top 
to bottom phosphocellulose (Whatman Pll) and 
Sephadex G-25 Fine (Pharmacia) in 20 mM Pipes 
and 0.5 mM MgS04 at pH 6.8. The 
phosphocellulose was pretreated with Mg*+ [8]. 
Tubulin was eluted in the void volume and the 
MAPS in one fraction by addition of 0.6 M NaCl 
to the same buffer. The MAPS fraction was further 
desalted on a Sephadex G-25, Pharmacia column 
in 0.1 M Pipes, 0.5 mM MgS04, 1 mM EDTA at 
pH 6.8. 
When required, the proteins were concentrated 
by pressure dialysis with an Amicon ultrafiltration 
cell and a PM30 membrane at 4°C. Protein solu- 
tions were stored in liquid nitrogen after drop 
freezing. 
2.3. Protein concentration 
Microtubule protein concentration was deter- 
mined according to Lowry et al. [9] with bovine 
serum albumin as a standard. 
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2.4. Assembly 
Assembly of microtubule proteins in assembly 
buffer, 0.1 M Pipes, 0.5 mM MgS04, 1 mM 
EDTA and 1 mM GTP was started by increasing 
the temperature from 4 to 37°C and was moni- 
tored continuously by the change in absorbance at 
350 nm. Estramustine phosphate or an equivalent 
amount of buffer was added from a stock solution 
to the proteins at 4°C. Taxol was added from a 
3 mM stock solution in dimethyl sulfoxide. 300 ~1 
of the solution with the assembled microtubules 
were pelleted through a 6 ml 50% (w/w) sucrose 
cushion in the same buffer by ultracentrifugation 
for 1 h at 100000 x g and the pellet was analysed 
by SDS-polyacrylamide gel electrophoresis 
(PAGE). 
2.5. SDS-PAGE 
SDS-PAGE was performed according to the 
method of O’Farrell [lo] on a linear (5-12%) gra- 
dient. Gels were stained with 0.25% Coomassie 
brilliant blue in methanol :acetic acid : water 
(5 : 1: 5), and destained in 7% acetic acid and 5% 
methanol. 
2.6. Gel filtration 
Microtubule proteins, tubulin and MAPS, 
respectively, 1 ml, were incubated with 
estramustine [6,7-3H]phosphate in 0.1 M Pipes, 
0.5 mM MgS04, 1 mM EDTA for 10 min at 4°C 
and separated from free estramustine phosphate 
on a Biogel P-6DG column (9 x 1.3 cm). The ab- 
sorbance at 280 nm was determined in each 1 ml 
fraction as a measure for the protein content. 
GTP, which also absorbs in ultraviolet, was 
therefore not present in the incubation mixture. 
However, we found that the presence of GTP did 
not alter the results. Each fraction was thereafter 
transferred to a scintillation vial with 10 ml scin- 
tillation solution: 2 parts toluene, 1 part Triton 
X-100 and 5 g/l Permablend (Packard Ltd) and 
counted in a LKB Wallac Rackbeta Liquid Scin- 
tillation Counter. 
3. RESULTS AND DISCUSSION 
We reported that estramustine phosphate in- 
hibits microtubule assembly in vitro [l]. Here, it 
was found that addition of more MAPS 
counteracted the inhibition of microtubule 
Volume 179, number 2 FEBS LETTERS January 1985 
assembly by estramustine phosphate (fig. 1). When 
MAPS were added to a concentration of 
0.5 mg/ml to 2 mg/ml microtubule proteins in- 
hibited by 0.2 mM estramustine phosphate, 
assembly was reinduced and reached the same level 
as that of the microtubule proteins without any ad- 
ditions. A similar effect has recently been found 
when the inhibition of microtubule assembly by 
micromolar concentrations of heparin was 
counteracted by additional MAPS [l 11. Both 
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Fig. 1, Effect of estramustine phosphate on microtubule 
assembly in the presence of additional microtubule 
associated proteins. Microtubule proteins were 
assembled at 37°C in buffer (0.1 M Pipes, 1 mM GTP, 
0.5 mM MgS04 and 1 mM EDTA at pH 6.8) as 
monitored by the absorbance difference at 350 nm, 
(Asso), against time. Estramustine phosphate was added 
to the protein samples at 4°C. The level of assembly is 
given as the absorbance difference at 350 nm vs the 
additionally added microtubule associated proteins 
(mg/ml), present initially. (0) No estramustine 
phosphate added; (0) in the presence of 0.2 mM 
estramustine phosphate. The microtubule protein 
concentration was originally 2.1 mg/ml. 
estramustine phosphate and heparin increased the 
critical protein concentration of assembly and fur- 
thermore in both cases the inhibition could be 
relieved by taxol [l,ll]. An increase in the critical 
concentration has also been seen in the presence of 
DNA [12], which binds to MAPS and inhibits the 
MAPS-dependent nucleation phase of assembly. 
These effects are quite different from those of the 
typical tubulin-binding drugs such as colchicine, 
vinblastine and nocodazole, which neither increase 
the critical protein concentration nor can be 
counteracted by MAPS (unpublished) or taxol [ 131. 
In order to further determine whether 
estramustine phosphate binds to MAPS, 
3H-labelled estramustine phosphate was incubated 
with either the microtubule proteins, consisting of 
80% tubulin and 2Ovo MAPS or purified tubulin, 
or the MAPS fraction. It was found by gel filtra- 
tion that estramustine phosphate binds to MAPS 
(fig.2C) and to a comparable lower extent to 
microtubule proteins (fig.2A), but only to a small 
degree to tubulin (fig.2B). The chromatograph 
shows that protein-bound estramustine phosphate 
is relatively well separated from free estramustine 
phosphate without extensive tailing, indicating 
that estramustine phosphate has a rather high af- 
finity for MAPS. Preliminary results have also 
shown that the pellet of taxol induced microtubule 
protein assembled in the presence of 3H-labelled 
estramustine phosphate was not enriched in 3H. As 
the pellet mainly consists of tubulin this supports 
the hypothesis that estramustine phosphate does 
not associate with tubulin but only with the MAPS 
which are left in the supernatant. 
A reduced content of all the MAPS was found in 
the taxol-reversed estramustine phosphate- 
inhibited microtubules, as judged from the 
SDS-PAGE (fig.3). The results suggest that 
estramustine phosphate inhibits assembly by bind- 
ing to MAPS a complex, which cannot bind to 
tubulin and induce assembly. Taxol is able to 
reverse the inhibition by estramustine phosphate or 
heparin [l ,111 as taxol can induce tubulin to 
assemble into microtubule in the absence of MAPS 
[ 131. However, we cannot yet decide if 
estramustine phosphate binds preferentially to a 
specific MAP or more or less unspecifically to all 
MAPS. A study with purified MAPS fractions is in 
progress. This question is of main interest in view 
of the recent findings that the composition of 
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Fig.2. Binding of estramustine [6,7-3H]phosphate o (A) 
microtubule proteins; (B) tubulin; (C) MAPS. The 
proteins were incubated with 0.4 mM estramustine 
[6,7-3H]phosphate for 10 min at 4°C and free and 
protein-bound drug were separated by gel filtration in 
0.1 M Pipes, 0.5 mM MgS04 and 1 mM EDTA. In each 
fraction, X-axis, the absorbance at 280 nm (- - -) and 
the ‘H (-) were determined as a measure of the 
protein and the estramustine phosphate content, 
respectively. 
MAPS can vary between different cell types and 
also within different parts of the cell [14-171. Fur- 
thermore, estramustine phosphate might be useful 
as a tool to unravel the action of the MAPS on 
microtubule assembly. 
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Fig.3. SDS-PAGE of the pellet of microtubule proteins 
assembled in the presence of: 0.25 mM estramustine 
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standard conditions. The assembly conditions were as 
described in the legend to fig. 1. 300~1 microtubule 
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the SDS-PAGE sample buffer immediately after 
centrifugation. 
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